
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of UCB SA NPV by UCB S.A. (OTCPK:UCBJF) through any online brokerage.
There are no as such competitors for UCB SA NPV by UCB S.A..
There is no analysis for UCB SA NPV by UCB S.A. to provide a consensus price target.
The stock price for UCB SA NPV by UCB S.A. (OTCPK: UCBJF) is $232.625 last updated October 9, 2026 at 12:33 PM EDT.
There are no upcoming dividends for UCB SA NPV by UCB S.A..
UCB SA NPV by UCB S.A. does not have any upcoming earnings scheduled.
There is no upcoming split for UCB SA NPV by UCB S.A..
UCB SA NPV by UCB S.A. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which...